The current PE ratio for Amgen stock as of Oct 4, 2024 is 54.64. This is calculated based on the current EPS of $5.85 and the stock price of $319.66 per share. The P/E ratio has grown by 61% from the past four quarters average of 33.9.
The average historical PE ratio of Amgen for the last ten years is 23.62. The current PE ratio of 54.64 is 131% above the historical average. Over the past ten years, AMGN's PE ratio was at its highest in the Dec 2017 quarter at 64.17, when the stock price was $173.9 and the EPS was $2.71. The lowest value was in the Dec 2016 quarter, when it reached 14.17 with a price of $146.21 and an EPS of $10.32.
Maximum annual increase: 352.86% in 2017
Maximum annual decrease: -76.11% in 2018
Year | PE ratio | Change |
---|---|---|
2023 | 22.93 | 6.35% |
2022 | 21.56 | -0.92% |
2021 | 21.76 | 17.37% |
2020 | 18.54 | -0.32% |
2019 | 18.6 | 21.33% |
2018 | 15.33 | -76.11% |
2017 | 64.17 | 352.86% |
2016 | 14.17 | -20.12% |
2015 | 17.74 | -24.29% |
2014 | 23.43 | 38.64% |
AMGN's current P/E ratio is above the 3, 5 and 10-year historical averages.
AMGN's PE ratio is lower than its peer stocks LLY and ABBV, but it is greater than JNJ's and ABT's. Amgen is presently trading at a higher PE ratio (54.64) than its peer group average of 46.7.
Stock name | PE ratio | Market cap |
---|---|---|
JNJ Johnson & Johnson | 10.52 | $385.86B |
BIIB Biogen Inc | 23.3 | $27.05B |
ABT Abbott Laboratories | 35.42 | $195.98B |
AMGN Amgen Inc | 54.64 | $171.76B |
ABBV AbbVie Inc | 64.76 | $343.18B |
GILD Gilead Sciences Inc | 99.52 | $105.31B |
LLY ELI LILLY & Co | 108.85 | $843.18B |
BMY Bristol Myers Squibb Co | N/A | $109.4B |
PFE Pfizer Inc | N/A | $161.95B |
ILMN Illumina Inc | N/A | $22.53B |
AMGN's price to earnings ratio is 54.64 as of Oct 4, 2024.
Over the last 3 years, the average price to earnings ratio for AMGN stock is 24.78.
Over the last 5 years, the average price to earnings ratio for AMGN stock is 22.73.
In the last ten years, the Dec 2017 quarter recorded the highest quarterly PE ratio at 64.17.
The current price to earnings ratio of AMGN is 131% higher than the 10-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Oct 4, 2024), Amgen's stock price is $319.66. The earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $5.85. Therefore, Amgen's P/E ratio for today is 54.64. PE RATIO(54.64) = STOCK PRICE($319.66) / TTM EPS($5.85)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.